DGAP-News: Media and Games Invest plc / Key word(s): Miscellaneous Media and Games Invest publishes bond prospectus and applies for listing of the bonds on Nasdaq Stockholm 08.01.2021
DGAP-News: Media and Games Invest plc / Key word(s): Miscellaneous Media and Games Invest publishes bond prospectus and applies for listing of the bonds on Nasdaq Stockholm 08.01.2021
DGAP-News: Media and Games Invest plc / Key word(s): Miscellaneous Media and Games Invest publishes bond prospectus and applies for listing of the bonds on Nasdaq Stockholm 08.01.2021 / 15:30 The issuer is solely responsible for the content of this announcement. Media and Games Invest publishes .
Alligator Bioscience publishes prospectus in connection with forthcoming rights issue
STOCKHOLM, Dec. 30, 2020 /PRNewswire/ T
he Board of Directors of Alligator Bioscience AB (publ) ( Alligator or the Company ) has, in connection with the rights issue of shares which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the Annual General Meeting on May 5, 2020 (the Rights Issue ), prepared a prospectus (the Prospectus ) that today has been approved and registered by the Swedish Financial Supervisory Authority.
To ensure continued successful development in accordance with the Company s business plan and strategy, the Board of Directors of Alligator has resolved to carry out the Rights Issue of approximately SEK 86 million before issue costs. The expected net proceeds from the Rights Issue will be used to initiate and conduct Phase II studies for mitazalimab and to complete phase I study and initiate preparatory work on Phase II s
Offer document regarding Roar BidCo AB s cash offer to the shareholders and Holders of Convertible Bonds in Recipharm AB (publ) made public: EQT
Tel: + 46 8 506 55 334, email: press@eqtpartners.com
For administrative questions regarding the Offer, please contact your bank or the nominee registered as holder of your shares, or, in respect of the Convertible Bonds, Lucid Issuer Services Limited:
Lucid Issuer Services Limited
Attention: Owen Morris
Email: recipharm@lucid-is.com
The information in this press release was submitted for publication by Roar BidCo (contact details to EQT Press Office above) in accordance with the Takeover Rules. The information was submitted for publication on 17 December 2020 at 11.30 (CET).